***FOR IMMEDIATE RELEASE***
UPPR Announces Strategic Relationship with Frontier Therapeutics to Support Veteran Healthcare Initiatives
Redondo Beach, Calif. – February 5, 2026 – UPPR Street Marketing, Inc. (“UPPR”) today announced a strategic teaming relationship with Frontier Therapeutics, Inc., a medical technology company focused on automated patient care solutions. The companies will jointly pursue opportunities across U.S. government, private healthcare, and in-home care markets related to automated lateral patient turning and repositioning systems utilizing Frontier’s FDA-cleared Toto® Cradle technology.
The Toto® Cradle is designed to help prevent and treat pressure injuries by automating and standardizing patient repositioning. The system supports improved patient safety, reduces physical strain on caregivers, and promotes more consistent quality of care—key priorities for healthcare providers seeking to improve outcomes across large, distributed care networks.
Under the relationship, UPPR will act as the prime contractor and commercial lead, leveraging its experience in federal market development, contracting, and stakeholder engagement. Frontier Therapeutics will serve as the exclusive technology partner and manufacturer, supplying its proprietary automated lateral patient turning system in support of government and private-sector contracts.
“This relationship reflects UPPR’s focus on working with proven technologies that address real-world challenges in large healthcare systems,” said John D. Quinn, Chairman and CEO of UPPR Street Marketing, Inc. “By combining UPPR’s federal market expertise with Frontier’s established, FDA-cleared technology, we believe this collaboration positions us well to support veteran and bed-bound patient populations while creating meaningful, long-term value for stakeholders.”
“Partnering with UPPR provides a focused and experienced pathway into government, private, and in-home care provider networks,” said Joe Bockus, President of Frontier Therapeutics, Inc. “UPPR’s understanding of federal markets and commitment to execution align well with our mission to expand access to technologies that improve patient outcomes and protect caregivers. We’re excited to work together in support of veterans’ care.”
Strategic Benefits
The relationship is expected to provide several potential benefits to UPPR and its shareholders, including:
- Revenue participation without manufacturing exposure
- Capital-efficient growth
- Long-term expansion potential across veteran-serving healthcare systems
UPPR believes this collaboration strengthens its portfolio of government-focused healthcare initiatives and supports its long-term objective of building durable, high-quality revenue streams through disciplined execution. The company will continue to provide updates to shareholders as opportunities advance and key milestones are reached.
About UPPR Street Marketing, Inc.
Upper Street Marketing, Inc. is more than a holding company—we are a catalyst for innovation and excellence. By acquiring and empowering businesses in medical technology, security, and premium spirits, we create a portfolio of distinctive brands that lead their industries. Our commitment is simple: identify proven strengths, unlock potential, and deliver sustainable growth. At Upper Street Marketing, we invest in what matters—innovation, integrity, and impact.
About Frontier Therapeutics, Inc.
Frontier Therapeutics, Inc. is a medical technology company dedicated to developing and commercializing clinically validated solutions that enhance patient care and caregiver safety. Frontier is the developer and manufacturer of the Toto® Cradle, an FDA-cleared automated lateral patient turning and repositioning system designed to support the prevention and treatment of pressure injuries.
Forward-Looking Statements
This press release contains forward-looking statements regarding anticipated market opportunities, business plans, and future performance. Actual results may differ materially due to risks and uncertainties inherent in federal contracting and technology deployment.
Media Inquiries:
John D. Quinn, Chairman & CEO
📧 john.quinn@upprinc.com
📞 310-623-7551
Investor Relations:
UPPR Street Marketing, Inc.
📧 investorrelations@upprinc.com
Cautionary Language Concerning Forward-Looking Statements
Statements in this newsletter may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend”, and similar expressions, as they relate to UPPR or its management, identify forward-looking statements. These statements are based on current expectations, estimates, and projections about the UPPR’s business, based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Such statements could be affected by risks and uncertainties related to: (i) UPPR’s ability to execute its business plans, (ii) product demand, market, and customer acceptance of UPPR’s products, (iii) UPPR’s ability to obtain financing to expand its operations, (iv) UPPR’s ability to attract qualified sales representatives for its products, (v) competition, pricing and development difficulties, (vi) UPPR’s ability to conduct its business if there are changes in laws, regulations, or government policies related to its products, (vii) UPPR’s ability to conduct operations if it faces product recalls, and (viii) general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date of this newsletter, and UPPR does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this newsletter.